arrow_back Back to App

Safer Medications: Better Dosing Through Genetics

This act aims to enhance medication safety by better tailoring drugs and their dosages to individual patient genetic profiles. This will help citizens avoid adverse drug reactions, increasing treatment effectiveness and reducing complication risks. Changes include educating healthcare professionals and improving electronic health record systems.
Key points
Better Drug Matching: Doctors will have genetic information to select safer drugs and dosages for each patient.
Fewer Side Effects: The risk of adverse drug reactions will decrease, improving treatment safety and comfort.
Improved Medical Records: Electronic systems will better support doctors in medication decisions, considering patient genetics.
Healthcare Professional Education: Medical staff will be trained on using genetic tests in treatment.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_7848
Sponsor: Rep. Swalwell, Eric [D-CA-14]
Process start date: 2024-03-29
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Right Drug Dose Now Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_7848.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-03-29.

What are the main provisions?

Key points include:

  • Better Drug Matching: Doctors will have genetic information to select safer drugs and dosages for each patient.
  • Fewer Side Effects: The risk of adverse drug reactions will decrease, improving treatment safety and comfort.
  • Improved Medical Records: Electronic systems will better support doctors in medication decisions, considering patient genetics.
  • Healthcare Professional Education: Medical staff will be trained on using genetic tests in treatment.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Swalwell, Eric [D-CA-14].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health